Changes in Beneficial Ownership · 4
ResMed Inc.
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-10-07
- Issuer
- RESMED INC
- Issuer CIK
- 0000943819
- Trading symbol
- RMD
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Farrell Michael J.
- Reporting owner CIK
- 0001485164
- Relationship
- Director · Officer
- Officer title
- Chairman and CEO
- Address
- RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO, CA, 92123
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| ResMed Common Stock | 2026-10-07 | M · Form 4[F1] | 4,991 | A | 146.34 | 484,794 | D |
| ResMed Common Stock | 2026-10-07 | S · Form 4[F1] | 4,991 | D | 226.3349[F2] | 479,803 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| ResMed Common Stock | 2,090 | I | Lisette and Michael Farrell Family Trust |
Table key
- I
- Indirect
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options | 146.34 | 2026-10-07 | M · Form 4[F1] | 4,991 | D | 0 | 2020-11-11[F3] | 2026-11-21 | ResMed Common Stock | 4,991 | 4,993 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
Signature 1
- Signed
- /s/ Michael J. Farrell, Chairman and CEO
- Date
- 2026-10-08
Company context
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersNov 19, 2026
- 10-Q filingOct 30, 2026
- Results of Operations and Financial Condition · Other EventsOct 29, 2026
- ARS filingOct 1, 2026
- DEFA14A filingOct 1, 2026